Polymer functionalized single walled carbon nanotubes mediated drug delivery of gliotoxin in cancer cells

Journal of Biomedical Nanotechnology

Volumn 10, Issue 1, 2014, Pages 120-130

  Bhatnagar, Ira ^a,b   Venkatesan, Jayachandran ^a   Kim, Se Kwon ^a  

^a Pukyong National University   (South Korea)

^b CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Biomaterials; Cancer; Carbon nanotube; Chitooligosaccharides; Gliotoxin; Polymer conjugates; Targeted drug delivery

Indexed keywords

CANCER; CHITOOLIGOSACCHARIDES; GLIOTOXIN; POLYMER CONJUGATE; TARGETED DRUG DELIVERY;

BIOLOGICAL MATERIALS; BIOMATERIALS; CARBON NANOTUBES; CELL DEATH; CHEMICAL ANALYSIS; CONJUGATED POLYMERS; DISEASES; DRUG DELIVERY; ENZYMES; POLYMERS;

CYTOTOXICITY;

CHITOSE OLIGOSACCHARIDE; FOLIC ACID; GLIOTOXIN; LYSOZYME; OLIGOSACCHARIDE; PROTEIN P53; SINGLE WALLED NANOTUBE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CHEMICAL INTERACTION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOTOXICITY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG TARGETING; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; HUMAN; HUMAN CELL; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CHITIN; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; GLIOTOXIN; HELA CELLS; HUMANS; MCF-7 CELLS; NANOTUBES, CARBON; NEOPLASMS; OLIGOSACCHARIDES; POLYMERS;

EID: 84889054807     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1677     Document Type: Article

References (44)

1. I. Ali, W. A. Wani, and K. Saleem, Cancer Scenario in India with Future Perspectives. Cancer Therapy 8, 56 (2011).
2. R. Misra, S. Acharya, and S. K. Sahoo, Cancer nanotechnology: application of nanotechnology in cancer therapy. Drug Discovery Today 15, 842 (2010).
3. C. Chen, X. X. Xie, Q. Zhou, F. Y. Zhang, Q. L. Wang, Y. Q. Liu, Y. Zou, Q. Tao, X. M. Ji, and S. Q. Yu. EGF-functionalized single-walled carbon nanotubes for targeting delivery of etoposide. Nanotechnology 23, 045104 (2012).
4. T. M. Allen and P. R. Cullis, Drug delivery systems: entering the mainstream. Science 303, 1818 (2004).
5. A. A. Bhirde, V. Patel, J. Gavard, G. Zhang, A. A. Sousa, A. Masedunskas, R. D. Leapman, R. Weigert, J. S. Gutkind, and J. F. Rusling, Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. Acs Nano 3, 307 (2009).
6. C. Lam, J. T. James, R. McCluskey, S. Arepalli, and R. L. Hunter, A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. CRC Critical Reviews in Toxicology 36, 189 (2006).
7. N. Ashok Kumar, H. S. Ganapathy, J. S. Kim, Y. S. Jeong, and Y. T. Jeong, Preparation of poly 2-hydroxyethyl methacrylate functionalized carbon nanotubes as novel biomaterial nanocomposites. Eur. Polym. J. 44, 579 (2008).
8. A. Elhissi, W. Ahmed, I. U. Hassan, V. Dhanak, and A. D'Emanuele. Carbon nanotubes in cancer therapy and drug delivery. Journal of Drug Delivery 2012, 10 (2011).
9. L. Meng, X. Zhang, Q. Lu, Z. Fei, and P. J. Dyson, Single walled carbon nanotubes as drug delivery vehicles: Targeting doxorubicin to tumors. Biomaterials 33, 1689 (2012).
10. C. M. Sayes, F. Liang, J. L. Hudson, J. Mendez, W. Guo, J. M. Beach, V. C. Moore, C. D. Doyle, J. L. West, and W. E. Billups, Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol. Lett. 161, 135 (2006).
11. A. Bianco, R. Sainz, S. Li, H. Dumortier, L. Lacerda, K. Kostarelos, S. Giordani, and M. Prato, Biomedical applications of functionalised carbon nanotubes. Medicinal Chemistry and Pharmacological Potential of Fullerenes and Carbon Nanotubes 23 (2008).
12. N. G. Sahoo, S. Rana, J. W. Cho, L. Li, and S. H. Chan, Polymer nanocomposites based on functionalized carbon nanotubes. Prog. Polym. Sci. 35, 837 (2010).
13. O. Felt, P. Buri, and R. Gurny, Chitosan: a unique polysaccharide for drug delivery. Drug Dev. Ind. Pharm. 24, 979 (1998).
14. M. Prabaharan and J. Mano, Chitosan-based particles as controlled drug delivery systems. Drug Deliv. 12, 41 (2004).
15. Y. J. Jeon, P. J. Park, and S. K. Kim, Antimicrobial effect of chitooligosaccharides produced by bioreactor. Carbohydr. Polym. 44, 71 (2001).
16. S. K. Kim and N. Rajapakse, Enzymatic production and biological activities of chitosan oligosaccharides (COS): A review. Carbohydr. Polym. 62, 357 (2005).
17. L. Carson, C. Kelly-Brown, M. Stewart, A. Oki, G. Regisford, Z. Luo, and V. I. Bakhmutov, Synthesis and characterization of chitosan-carbon nanotube composites. Mater. Lett. 63, 617 (2009).
18. J. Venkatesan, Z. J. Qian, B. M. Ryu, N. Ashok Kumar, and S. K. Kim, Preparation and characterization of carbon nanotube-grafted-chitosan-Natural hydroxyapatite composite for bone tissue engineering. Carbohydr. Polym. 83, 569 (2011).
19. J. Venkatesan and S. K. Kim, Chitosan composites for bone tissue engineering - An overview. Mar. Drugs 8, 2252 (2010).
20. H. Liao, R. Qi, M. Shen, X. Cao, R. Guo, Y. Zhang, and X. Shi, Improved cellular response on multiwalled carbon nanotubein-corporated electrospun polyvinyl alcohol/chitosan nanofibrous scaffolds. Colloids Surf. B. Biointerfaces 84, 528 (2011).
21. C. Chen, X. X. Xie, Q. Zhou, F. Y. Zhang, Q. L. Wang, Y. Q. Liu, Y. Zou, Q. Tao, X. M. Ji, and S. Q. Yu, EGF-functionalized single-walled carbon nanotubes for targeting delivery of etoposide. Nanotechnology 23, 045104 (2012).
22. Y. S. Guan, Q. He, and Z. La, Roles of p53 in carcinogenesis, diagnosis and treatment of hepatocellular carcinoma. J. Canc. Mol 2, 191 (2006).
23. W. A. K. M. Windt, J. Prakash, R. J. Kok, F. Moolenaar, C. A. Kluppel, D. de Zeeuw, R. P. E. van Dokkum, and R. H. Henning, Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis. Journal of Renin-Angiotensin-Aldosterone System 5, 197 (2004).
24. M. C. Wright, R. Issa, D. E. Smart, N. Trim, G. I. Murray, J. N. Primrose, M. J. P. Arthur, J. P. Iredale, and D. A. Mann, Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 121, 685 (2001).
25. W. I. Hagens, P. Olinga, D. K. F. Meijer, G. M. M. Groothuis, L. Beljaars, and K. Poelstra, Gliotoxin non-selectively induces apoptosis in fibrotic and normal livers. Liver International 26, 232 (2006).
26. J. Venkatesan and S. K. Kim, Stimulation of minerals by carbon nanotube grafted glucosamine in mouse mesenchymal stem cells for bone tissue engineering. Journal of Biomedical Nanotechnology 8, 676 (2012).
27. F. Pompeo and D. E. Resasco, Water solubilization of single-walled carbon nanotubes by functionalization with glucosamine. Nano Lett. 2, 369 (2002).
28. S. Iijima, Helical microtubules of graphitic carbon. Nature 354, 56 (1991).
29. D. Tasis, N. Tagmatarchis, A. Bianco, and M. Prato, Chemistry of carbon nanotubes. Chemical Reviews 106, 1105 (2006).
30. P. A. Mello, L. F. Rodrigues, M. A. G. Nunes, J. C. P. Mattos, E. I. Müller, V. L. Dressler, and E. M. M. Flores, Determination of metal impurities in carbon nanotubes by direct solid sampling electrothermal atomic absorption spectrometry. Journal of the Brazilian Chemical Society 22, 1040 (2011).
31. M. Trojanowicz, Analytical applications of carbon nanotubes: a review. TrAC Trends in Analytical Chemistry 25, 480 (2006).
32. C.-W. Lam, J. T. James, R. McCluskey, S. Arepalli, and R. L. Hunter. A Review of Carbon Nanotube Toxicity and Assessment of Potential Occupational and Environmental Health Risks. Critical Reviews in Toxicology 36, 189 (2006).
33. R. H. Hurt, M. Monthioux, and A. Kane, Toxicology of carbon nanomaterials: Status, trends, and perspectives on the special issue. Carbon 44, 1028 (2006).
34. A. Ismail, P. S. Goh, J. C. Tee, S. M. Sanip, and M. Aziz, A review of purification techniques for carbon nanotubes. Nano 3, 127 (2008).
35. P. X. Hou, C. Liu, and H. M. Cheng, Purification of carbon nanotubes. Carbon 46, 2003 (2008).
36. A. Hirsch and O. Vostrowsky, Functionalization of carbon nanotubes. Functional molecular nanostructures 193 (2005).
37. M.-M. Kim and S.-K. Kim, Chitooligosaccharides inhibit activation and expression of matrix metalloproteinase-2 in human dermal fibroblasts. FEBS Lett. 580, 2661 (2006).
38. S. DeWitte-Orr and N. Bols, Gliotoxin-induced cytotoxicity in three salmonid cell lines: cell death by apoptosis and necrosis. Comparative Biochemistry and Physiology Part C: Toxicology and Pharmacology 141, 157 (2005).
39. Y. O. Kweon, Y. H. Paik, B. Schnabl, T. Qian, J. J. Lemasters, and D. A. Brenner, Gliotoxin-mediated apoptosis of activated human hepatic stellate cells. Journal of hepatology 39, 38 (2003).
40. R. Vermeij, N. Leffers, S. H. van der Burg, C. J. Melief, T. Daemen, and H. W. Nijman, Immunological and Clinical Effects of Vaccines Targeting p53-Overexpressing Malignancies. Journal of Biomedicine and Biotechnology 2011, 11 (2011).
41. I. M. Svane, A. E. Pedersen, H. E. Johnsen, D. Nielsen, C. Kamby, E. Gaarsdal, K. Nikolajsen, S. Buus, and M. H. Claesson, Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study. Cancer Immunology Immunotherapy 53, 633 (2004).
42. N. Leffers, A. J. A. Lambeck, M. J. M. Gooden, B. N. Hoogeboom, R. Wolf, I. E. Hamming, B. G. Hepkema, P. H. B. Willemse, B. H. W. Molmans, and H. Hollema, Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial. International Journal of Cancer 125, 2104 (2009).
43. Z. Darzynkiewicz, S. Bruno, G. Del Bino, W. Gorczyca, M. Hotz, P. Lassota, and F. Traganos, Features of apoptotic cells measured by flow cytometry. Cytometry 13, 795 (1992).
44. I. Nicoletti, G. Migliorati, M. Pagliacci, F. Grignani, and C. Riccardi, A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. Journal of Immunological Methods 139, 271 (1991).